Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Crohn's Disease
Crohn's Disease
Johnson & Johnson shows off under-pressure Stelara's latest indication—Crohn's—in new DTC spot
Fierce Pharma
Wed, 08/2/17 - 11:30 am
JNJ
Stelara
Crohn's Disease
drug advertising
DTC ads
Johnson & Johnson commits $990M to land Protagonist’s oral Crohn’s drug
Fierce Biotech
Tue, 05/30/17 - 06:20 pm
JNJ
Protagonist Therapeutics
M&A
Crohn's Disease
PTG-200
AbbVie's JAK-1 inhibitor hits the mark in Crohn's disease
BioPharma Dive
Thu, 05/11/17 - 11:17 am
AbbVie
JAK inhibitors
Crohn's Disease
Upadacitinib
Pfizer and Celltrion Seek Biosimilar Interchangeability for Crohn’s Disease Drug
Xtalks
Mon, 02/27/17 - 10:02 pm
Pfizer
Celltrion
biosimilars
Crohn's Disease
Inflectra
Remicade
Takeda, TiGenix stem cell therapy shows sustained effect
Fierce Biotech
Sun, 02/19/17 - 12:16 pm
Takeda
TiGenix
stem cells
Cx601
Crohn's Disease
Gilead Takes Lead on Crohn's over AbbVie
Investopedia
Mon, 11/28/16 - 11:33 pm
Gilead Sciences
AbbVie
Crohn's Disease
Galapagos
filgotinib
ABT-494
Celgene Skips the Placebo, Fails Drug Development 101
TheStreet.com
Wed, 10/19/16 - 10:51 am
Celgene
drug development
clinical trials
placebo
GED-0301
Crohn's Disease
Celgene Crohn's Pill Data Unspectacular but Perhaps Good Enough
TheStreet.com
Mon, 10/17/16 - 11:39 am
Celgene
Crohn's Disease
GED-0301
Could J&J's recent news about its rheumatoid arthritis and Crohn's disease drugs threaten AbbVie's Humira?
Motley Fool
Thu, 10/13/16 - 11:18 am
JNJ
rheumatoid arthritis
Crohn's Disease
AbbVie
Humira
sirukumab
AstraZeneca hands off another Amgen-partnered drug in a $1.5B deal with an acquisitive Allergan
Endpoints
Mon, 10/3/16 - 10:09 am
AstraZeneca
Amgen
Allergan
MEDI2070
ulcerative colitis
Crohn's Disease
Will Gilead (GILD) Stock Be Helped by Positive Crohn's Drug Results?
TheStreet.com
Mon, 09/26/16 - 03:25 pm
Gilead Sciences
Crohn's Disease
filgotinib
Galapagos
Celgene’s update on its big Crohn’s drug? Trust us, we’re doing fine
Endpoints
Mon, 09/12/16 - 09:27 am
Celgene
Crohn's Disease
GED-0301
How AbbVie Expects Risankizumab to Be a Transformative Therapy
Market Realist
Wed, 08/24/16 - 10:40 am
AbbVie
risankizumab
Crohn's Disease
Next Up for Celgene's Crohn's Pill: A Snapshot Inside Patients' Colons
TheStreet.com
Fri, 07/15/16 - 10:41 am
Celgene
Crohn's Disease
GED-0301
Otezla
ozanimod
AbbVie’s Newly Licensed Drug Scores Against Crohn’s Disease
Investors.com
Tue, 05/24/16 - 11:54 pm
AbbVie
Crohn's Disease
risankizumab
Boehringer Ingelheim
J&J psoriasis drug Stelara tames Crohn's disease in second trial
Yahoo/Reuters
Fri, 03/18/16 - 10:41 am
JNJ
psoriasis
Stelara
Crohn's Disease
Galapagos' inflammation drug comes through in Crohn's with Phase III in sight
Fierce Biotech
Tue, 12/8/15 - 10:54 pm
Galapagos
Crohn's Disease
filgotinib
AstraZeneca Sells Drug Rights To Perrigo
Bidness, ETC
Mon, 11/23/15 - 09:33 am
AstraZeneca
Perrigo Company
Entocort
Crohn's Disease
J&J's Stelara succeeds in Phase III Crohn's disease trial
Yahoo/Reuters
Mon, 10/19/15 - 09:56 am
JNJ
Stelara
Crohn's Disease
clinical trials
Does Celgene Have Another Blockbuster on the Way?
Investopedia
Thu, 03/26/15 - 09:45 pm
Celgene
GED-0301
autoimmune disease
Crohn's Disease
Pages
« first
‹ previous
1
2
3
4
5
next ›
last »